Skip to main content
. 2021 Jan;10(1):126–140. doi: 10.21037/tcr-20-2712

Figure 6.

Figure 6

Relationship between expression of six hub genes and genetic characteristics of AML patients through BloodSpot database. (A) FLT3; (B) PF4; (C) CD163; (D) MRC1; (E) CSF2RB; (F) PPBP. FLT3, FMS-related tyrosine kinase 3; PF4, platelet factor 4; CD163, the macrophage scavenger receptor; MRC1, mannose receptor C-type 1; CSF2RB, colony stimulating factor 2 receptor subunit beta; PPBP, pro-platelet basic protein; AML, acute myeloid leukemia.